A spatiotemporal Notch interaction map from plasma membrane to nucleus.


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
08 2023
Historique:
medline: 3 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

Notch signaling relies on ligand-induced proteolysis of the transmembrane receptor Notch to liberate a nuclear effector that drives cell fate decisions. Upon ligand binding, sequential cleavage of Notch by the transmembrane protease ADAM10 and the intracellular protease γ-secretase releases the Notch intracellular domain (NICD), which translocates to the nucleus and forms a complex that induces target gene transcription. To map the location and timing of the individual steps required for the proteolysis and movement of Notch from the plasma membrane to the nucleus, we used proximity labeling with quantitative, multiplexed mass spectrometry to monitor the interaction partners of endogenous NOTCH2 after ligand stimulation in the presence of a γ-secretase inhibitor and as a function of time after inhibitor removal. Our studies showed that γ-secretase-mediated cleavage of NOTCH2 occurred in an intracellular compartment and that formation of nuclear complexes and recruitment of chromatin-modifying enzymes occurred within 45 min of inhibitor washout. These findings provide a detailed spatiotemporal map tracking the path of Notch from the plasma membrane to the nucleus and identify signaling events that are potential targets for modulating Notch activity.

Identifiants

pubmed: 37527352
doi: 10.1126/scisignal.adg6474
pmc: PMC10560377
mid: NIHMS1933198
doi:

Substances chimiques

Amyloid Precursor Protein Secretases EC 3.4.-
Ligands 0
Receptors, Notch 0
Receptor, Notch1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadg6474

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM130386
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002541
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA220340
Pays : United States
Organisme : NIGMS NIH HHS
ID : K99 GM144750
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA272484
Pays : United States

Références

Science. 2013 Mar 15;339(6125):1328-1331
pubmed: 23371551
J Biol Chem. 1991 Sep 15;266(26):17707-12
pubmed: 1832676
Cell Mol Life Sci. 2010 Sep;67(18):3187-96
pubmed: 20454918
Blood. 2005 Oct 15;106(8):2693-9
pubmed: 15976178
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nat Genet. 2011 Mar 06;43(4):303-5
pubmed: 21378985
Dev Cell. 2019 Aug 19;50(4):411-425.e8
pubmed: 31378591
Annu Rev Biophys. 2021 May 6;50:157-189
pubmed: 33534608
Mol Cell Biol. 2020 May 14;40(11):
pubmed: 32179552
Dev Cell. 2006 Jun;10(6):839-50
pubmed: 16740485
Mol Cell. 2004 Nov 19;16(4):509-20
pubmed: 15546612
Methods Enzymol. 2008;438:77-93
pubmed: 18413242
Genes Dev. 2013 May 1;27(9):1059-71
pubmed: 23651858
J Cell Biol. 2021 May 3;220(5):
pubmed: 33856408
Nat Genet. 1997 Jul;16(3):243-51
pubmed: 9207788
Cell. 2017 Apr 6;169(2):338-349.e11
pubmed: 28388415
Neuromolecular Med. 2010 Mar;12(1):1-12
pubmed: 20232515
J Cell Biochem. 2003 Apr 15;88(6):1256-64
pubmed: 12647307
Nat Rev Clin Oncol. 2020 Jul;17(7):435-448
pubmed: 32303701
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
pubmed: 24226387
Traffic. 2012 Feb;13(2):218-33
pubmed: 21995724
J Mol Biol. 2009 Jan 30;385(4):1015-31
pubmed: 19084535
Mol Oncol. 2014 Mar;8(2):207-20
pubmed: 24309677
J Med Genet. 2012 Feb;49(2):138-44
pubmed: 22209762
J Cell Sci. 2012 Oct 15;125(Pt 20):4693-702
pubmed: 23148298
J Proteomics. 2016 Oct 4;148:85-93
pubmed: 27432472
Genes Dev. 2002 Jun 1;16(11):1397-411
pubmed: 12050117
Annu Rev Pathol. 2017 Jan 24;12:245-275
pubmed: 27959635
Nat Commun. 2022 Oct 16;13(1):6112
pubmed: 36245040
PLoS One. 2013 Jul 01;8(7):e68247
pubmed: 23840889
Development. 2010 Jun;137(11):1825-32
pubmed: 20460366
Genet Res (Camb). 2019 Dec 27;101:e14
pubmed: 31878985
Cell. 2006 Mar 10;124(5):973-83
pubmed: 16530044
Anal Chem. 2014 Jul 15;86(14):7150-8
pubmed: 24927332
Nat Protoc. 2016 Mar;11(3):456-75
pubmed: 26866790
Blood Adv. 2021 Jan 12;5(1):71-83
pubmed: 33570635
Biochim Biophys Acta. 2016 Jan;1863(1):166-77
pubmed: 26522918
PLoS Genet. 2013;9(1):e1003162
pubmed: 23300480
J Neurochem. 2005 Mar;92(5):1010-20
pubmed: 15715652
Elife. 2022 May 18;11:
pubmed: 35583918
Mol Cell Biol. 2002 Nov;22(22):7812-9
pubmed: 12391150
Mol Biol Cell. 2011 Feb 1;22(3):375-85
pubmed: 21148287
EMBO Rep. 2019 May;20(5):
pubmed: 30914409
Mol Cell Biol. 2000 Mar;20(5):1825-35
pubmed: 10669757
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):705-10
pubmed: 24374627
Nature. 1995 Jul 13;376(6536):184-8
pubmed: 7603572
J Biol Chem. 2005 Feb 11;280(6):4383-92
pubmed: 15569674
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
FEBS J. 2015 Feb;282(3):445-62
pubmed: 25429850
Mol Cell Biol. 2001 Nov;21(22):7761-74
pubmed: 11604511
Nat Rev Mol Cell Biol. 2010 Apr;11(4):276-87
pubmed: 20308985
Cell. 2010 Dec 23;143(7):1174-89
pubmed: 21183079
Mol Cell Biol. 2000 Oct;20(20):7505-15
pubmed: 11003647
Methods Mol Biol. 2014;1187:247-54
pubmed: 25053495
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17761-6
pubmed: 22006338
J Med Genet. 2003 May;40(5):333-9
pubmed: 12746394
Biol Cell. 2000 Aug;92(5):305-16
pubmed: 11071040
Sci Signal. 2011 Jul 12;4(181):rs7
pubmed: 21775282
Curr Biol. 2000 Jun 29;10(13):R471-3
pubmed: 10898989
Front Immunol. 2013 Apr 08;4:84
pubmed: 23579783
Methods Mol Biol. 2019;2008:41-55
pubmed: 31124087
Blood. 2003 Mar 1;101(5):1784-9
pubmed: 12411302
EMBO Rep. 2019 Nov 5;20(11):e48150
pubmed: 31544310
Nat Methods. 2015 Jan;12(1):51-4
pubmed: 25419960
J Cell Biol. 2004 Jul 5;166(1):73-83
pubmed: 15240571
Nat Genet. 2000 Dec;26(4):484-9
pubmed: 11101851
Traffic. 2013 Dec;14(12):1272-89
pubmed: 24025110
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Autophagy. 2018;14(8):1435-1455
pubmed: 29940786
Development. 2019 Feb 1;146(3):
pubmed: 30709911
J Cell Sci. 2013 May 15;126(Pt 10):2135-40
pubmed: 23729744
Physiol Rev. 2017 Oct 1;97(4):1235-1294
pubmed: 28794168
Comb Chem High Throughput Screen. 2005 Mar;8(2):161-71
pubmed: 15777180
Dev Cell. 2015 Jun 22;33(6):729-36
pubmed: 26051539

Auteurs

Alexandre P Martin (AP)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Gary A Bradshaw (GA)

Department of Systems Biology, Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA.

Robyn J Eisert (RJ)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Emily D Egan (ED)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Lena Tveriakhina (L)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Julia M Rogers (JM)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Andrew N Dates (AN)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.

Gustavo Scanavachi (G)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.

Jon C Aster (JC)

Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.

Tom Kirchhausen (T)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.

Marian Kalocsay (M)

Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Stephen C Blacklow (SC)

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
Department of Cancer Biology, Dana Farber Cancer Institute, Boston, MA 02215, USA.

Articles similaires

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH